IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,517,000 | -71.0% | 300,000 | -88.3% | 0.31% | -78.6% |
| Q1 2023 | $39,721,110 | -12.6% | 2,561,000 | 0.0% | 1.45% | -24.3% |
| Q4 2022 | $45,457,750 | +237.7% | 2,561,000 | +101.1% | 1.92% | +280.6% |
| Q2 2021 | $13,461,000 | -26.6% | 1,273,516 | +11.3% | 0.50% | -26.7% |
| Q1 2021 | $18,350,000 | -22.8% | 1,144,016 | +122.4% | 0.69% | -26.4% |
| Q4 2020 | $23,759,000 | -43.7% | 514,370 | -57.1% | 0.94% | -59.3% |
| Q3 2020 | $42,173,000 | +59.1% | 1,198,427 | +10.1% | 2.30% | +40.6% |
| Q2 2020 | $26,504,000 | +70.3% | 1,088,479 | +8.8% | 1.63% | +12.6% |
| Q1 2020 | $15,565,000 | -1.8% | 999,996 | 0.0% | 1.45% | +20.7% |
| Q4 2019 | $15,850,000 | – | 999,996 | – | 1.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |